To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Metabotropic glutamate receptor subtype 5 (mGluR5; GRM5)

Neurology

INDICATION: Alzheimer's disease (AD)

Mouse studies suggest mGluR5 antagonists could help treat AD. In two

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE